These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32904022)

  • 1. Clinical and Radiographic Evaluation of Pulpotomy using MTA, Biodentine and Er,Cr:YSGG Laser in primary teeth- A Clinical Study.
    Ramanandvignesh P; Gyanendra K; Jatinder Kaur Goswami Mridula D
    Laser Ther; 2020 Jul; 29(1):29-34. PubMed ID: 32904022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of clinical outcome of indirect pulp treatment with calcium hydroxide, calcium silicate and Er,Cr:YSGG laser in permanent molars.
    E A; Gyanendra K; Dhillon JK
    Laser Ther; 2019 Jun; 28(2):123-130. PubMed ID: 32921911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Efficacy of Erbium, Chromium-doped Yttrium, Scandium, Gallium, and Garnet Laser in Partial Pulpotomy in Permanent Immature Molars: A Randomized Controlled Trial.
    Tozar KN; Erkmen Almaz M
    J Endod; 2020 May; 46(5):575-583. PubMed ID: 32229029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term treatment outcome of pulpotomies in primary molars using mineral trioxide aggregate and Biodentine: a randomized clinical trial.
    Cuadros-Fernández C; Lorente Rodríguez AI; Sáez-Martínez S; García-Binimelis J; About I; Mercadé M
    Clin Oral Investig; 2016 Sep; 20(7):1639-45. PubMed ID: 26578117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Evaluation of Success of Primary Teeth Pulpotomy Using Mineral Trioxide Aggregate(®), Laser and Biodentine(TM)- an In Vivo Study.
    Niranjani K; Prasad MG; Vasa AA; Divya G; Thakur MS; Saujanya K
    J Clin Diagn Res; 2015 Apr; 9(4):ZC35-7. PubMed ID: 26023640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of MTA and Biodentine as medicaments for pulpotomy in traumatized anterior immature permanent teeth: A randomized clinical trial.
    Abuelniel GM; Duggal MS; Kabel N
    Dent Traumatol; 2020 Aug; 36(4):400-410. PubMed ID: 32096595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Evaluation of Success of Biodentine and Mineral Trioxide Aggregate with Formocresol as Pulpotomy Medicaments in Primary Molars: An
    Ahuja S; Surabhi K; Gandhi K; Kapoor R; Malhotra R; Kumar D
    Int J Clin Pediatr Dent; 2020; 13(2):167-173. PubMed ID: 32742096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evaluation of MTA and Biodentine as a pulpotomy materials for carious exposures in primary teeth.
    Çelik BN; Mutluay MS; Arıkan V; Sarı Ş
    Clin Oral Investig; 2019 Feb; 23(2):661-666. PubMed ID: 29744721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Evaluation of Mineral Trioxide Aggregate Pulpotomy and Laser-Assisted Mineral Trioxide Aggregate Pulpotomy: An Original Research Article.
    Satyarth S; Alkhamis AM; Almunahi HF; Abdulaziz Alsuhaymi MO; Vadde HB; Senapathi SN; Shami AO; Aldrewesh RF; Nayyar AS
    J Microsc Ultrastruct; 2021; 9(1):7-11. PubMed ID: 33850706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and radiographic comparison of biodentine, mineral trioxide aggregate and formocresol as pulpotomy agents in primary molars.
    Juneja P; Kulkarni S
    Eur Arch Paediatr Dent; 2017 Aug; 18(4):271-278. PubMed ID: 28780718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Mineral Trioxide Aggregate and Biodentine as pulpotomy agents in immature first permanent molars with carious pulp exposure: A randomised clinical trial.
    Abuelniel GM; Duggal MS; Duggal S; Kabel NR
    Eur J Paediatr Dent; 2021; 22(1):19-25. PubMed ID: 33719478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Pulp Responses to Partial Pulpotomy Treatment with TheraCal as Compared with Biodentine and ProRoot MTA: A Clinical Trial.
    Bakhtiar H; Nekoofar MH; Aminishakib P; Abedi F; Naghi Moosavi F; Esnaashari E; Azizi A; Esmailian S; Ellini MR; Mesgarzadeh V; Sezavar M; About I
    J Endod; 2017 Nov; 43(11):1786-1791. PubMed ID: 28822566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative evaluation of four regenerative materials for pulpotomy in primary molars: An
    Manohar S; Bazaz N; Neeraja G; Subramaniam P; Sneharaj N
    Dent Res J (Isfahan); 2022; 19():102. PubMed ID: 36618772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Clinical and Radiological Outcomes of Pulpotomized Primary Molars Treated with Three Different Materials: Mineral Trioxide Aggregate, Biodentine, and Pulpotec. An In-vivo Study.
    Mythraiye R; Rao VV; Minor Babu MS; Satyam M; R P; Paravada C
    Cureus; 2019 Jun; 11(6):e4803. PubMed ID: 31404393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronal discoloration induced by calcium silicate-based cements used in full pulpotomy in mature permanent molars: a randomized clinical trial.
    Taha NA; Hamdan AM; Al-Hiyasat AS
    Clin Oral Investig; 2023 Apr; 27(4):1723-1730. PubMed ID: 36445467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MTA and biodentine for primary teeth pulpotomy: a systematic review and meta-analysis of clinical trials.
    Stringhini Junior E; Dos Santos MGC; Oliveira LB; Mercadé M
    Clin Oral Investig; 2019 Apr; 23(4):1967-1976. PubMed ID: 30238414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Vital Pulp Therapy Using Mineral Trioxide Aggregate or Biodentine: A Prospective Randomized Clinical Trial.
    Awawdeh L; Al-Qudah A; Hamouri H; Chakra RJ
    J Endod; 2018 Nov; 44(11):1603-1609. PubMed ID: 30292451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation and comparison of mineral trioxide aggregate and biodentine in primary tooth pulpotomy: Clinical and radiographic study.
    Carti O; Oznurhan F
    Niger J Clin Pract; 2017 Dec; 20(12):1604-1609. PubMed ID: 29378994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial pulpotomy with two bioactive cements in permanent teeth of 6- to 18-year-old patients with signs and symptoms indicative of irreversible pulpitis: a noninferiority randomized controlled trial.
    Uesrichai N; Nirunsittirat A; Chuveera P; Srisuwan T; Sastraruji T; Chompu-Inwai P
    Int Endod J; 2019 Jun; 52(6):749-759. PubMed ID: 30638262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of pulpal responses to pulpotomy and pulp capping with biodentine and mineral trioxide aggregate in dogs.
    De Rossi A; Silva LA; Gatón-Hernández P; Sousa-Neto MD; Nelson-Filho P; Silva RA; de Queiroz AM
    J Endod; 2014 Sep; 40(9):1362-9. PubMed ID: 25146016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.